[Current therapy concepts in patients with multiple myeloma].
Heyll
A
A
Klinik für Hämatologie Onkologie und klinische Immunologie, Universität Düsseldorf.
Schneider
P
P
Bauser
U
U
Kobbe
G
G
Hünerlitürkoglu
A
A
Aul
C
C
Haas
R
R
D000367:Age Factors; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004164:Diphosphonates / Q000627:therapeutic use; D004921:Erythropoietin / Q000627:therapeutic use; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D010954:Plasmacytoma / Q000532:radiotherapy / Q000628:therapy; D011446:Prospective Studies; D011879:Radiotherapy Dosage; D016032:Randomized Controlled Trials as Topic; D033581:Stem Cell Transplantation; D014182:Transplantation, Autologous
D004164:Diphosphonates; D007376:Interleukin-2; D004921:Erythropoietin; D007372:Interferons